TGFB1 and pancreatic neoplasm: Similarly, Soares et al. found that TGF-β inhibition combined with a allogeneic pancreas tumor vaccine secreting granulocyte/macrophage colony–stimulating factor (GM-CSF) dramatically increased effector CD8+ T lymphocyte infiltration and inhibited Tregs more significantly, followed by a survival advantage in a mouse trial [73].